- Home
- QURE vs AMC Comparison
QURE vs AMC Comparison
Compare QURE & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | AMC |
|---|---|---|
| Founded | 1998 | 1920 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 993.9M |
| IPO Year | 2013 | 2007 |
Fundamental Metrics
Financial Performance| Metric | QURE | AMC |
|---|---|---|
| Price | $46.70 | $2.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | ★ $45.00 | $2.03 |
| AVG Volume (30 Days) | 2.0M | ★ 39.4M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $13,107,000.00 | ★ $4,848,900,000.00 |
| Revenue This Year | $126.12 | $11.41 |
| Revenue Next Year | $200.43 | $5.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.57 |
| 52 Week Low | $8.73 | $0.93 |
| 52 Week High | $71.50 | $3.60 |
Technical Indicators
Market Signals| Indicator | QURE | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 79.16 | 77.22 |
| Support Level | $21.63 | $2.80 |
| Resistance Level | $60.70 | $3.13 |
| Average True Range (ATR) | 2.43 | 0.25 |
| MACD | 1.72 | 0.08 |
| Stochastic Oscillator | 84.49 | 92.37 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.